Galera Therapeutics, Inc. (GRTX)
0.1048
0.00 (0.00%)
USD |
OTCM |
May 27, 13:41
Galera Therapeutics Cash from Financing (Quarterly) : 0.00 for March 31, 2026
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| XOMA Royalty Corp. | -7.56M |
| ACADIA Pharmaceuticals, Inc. | 4.231M |
| Alnylam Pharmaceuticals, Inc. | 15.71M |
| Amgen, Inc. | 1.436B |
| Savara, Inc. | -0.195M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.875M |
| Free Cash Flow | -4.686M |
| Free Cash Flow Per Share (Quarterly) | -0.0089 |
| Free Cash Flow to Equity (Quarterly) | -0.875M |
| Free Cash Flow to Firm (Quarterly) | -0.875M |
| Free Cash Flow Yield | -48.17% |